Ontology highlight
ABSTRACT: Background
Fibrin fragment D-dimer, one of several peptides produced when crosslinked fibrin is degraded by plasmin, is the most widely used clinical marker of activated blood coagulation. To identity genetic loci influencing D-dimer levels, we performed the first large-scale, genome-wide association search.Methods and results
A genome-wide investigation of the genomic correlates of plasma D-dimer levels was conducted among 21 052 European-ancestry adults. Plasma levels of D-dimer were measured independently in each of 13 cohorts. Each study analyzed the association between ≈2.6 million genotyped and imputed variants across the 22 autosomal chromosomes and natural-log–transformed D-dimer levels using linear regression in additive genetic models adjusted for age and sex. Among all variants, 74 exceeded the genome-wide significance threshold and marked 3 regions. At 1p22, rs12029080 (P=6.4×10(-52)) was 46.0 kb upstream from F3, coagulation factor III (tissue factor). At 1q24, rs6687813 (P=2.4×10(-14)) was 79.7 kb downstream of F5, coagulation factor V. At 4q32, rs13109457 (P=2.9×10(-18)) was located between 2 fibrinogen genes: 10.4 kb downstream from FGG and 3.0 kb upstream from FGA. Variants were associated with a 0.099-, 0.096-, and 0.061-unit difference, respectively, in natural-log–transformed D-dimer and together accounted for 1.8% of the total variance. When adjusted for nonsynonymous substitutions in F5 and FGA loci known to be associated with D-dimer levels, there was no evidence of an additional association at either locus.Conclusions
Three genes were associated with fibrin D-dimer levels. Of these 3, the F3 association was the strongest, and has not been previously reported.
SUBMITTER: Smith NL
PROVIDER: S-EPMC3095913 | biostudies-literature | 2011 May
REPOSITORIES: biostudies-literature
Smith Nicholas L NL Huffman Jennifer E JE Strachan David P DP Huang Jie J Dehghan Abbas A Trompet Stella S Lopez Lorna M LM Shin So-Youn SY Baumert Jens J Vitart Veronique V Bis Joshua C JC Wild Sarah H SH Rumley Ann A Yang Qiong Q Uitterlinden Andre G AG Stott David J DJ Davies Gail G Carter Angela M AM Thorand Barbara B Polašek Ozren O McKnight Barbara B Campbell Harry H Rudnicka Alicja R AR Chen Ming-Huei MH Buckley Brendan M BM Harris Sarah E SE Peters Annette A Pulanic Drazen D Lumley Thomas T de Craen Anton J M AJ Liewald David C DC Gieger Christian C Campbell Susan S Ford Ian I Gow Alan J AJ Luciano Michelle M Porteous David J DJ Guo Xiuqing X Sattar Naveed N Tenesa Albert A Cushman Mary M Slagboom P Eline PE Visscher Peter M PM Spector Tim D TD Illig Thomas T Rudan Igor I Bovill Edwin G EG Wright Alan F AF McArdle Wendy L WL Tofler Geoffrey G Hofman Albert A Westendorp Rudi G J RG Starr John M JM Grant Peter J PJ Karakas Mahir M Hastie Nicholas D ND Psaty Bruce M BM Wilson James F JF Lowe Gordon D O GD O'Donnell Christopher J CJ Witteman Jacqueline C M JC Jukema J Wouter JW Deary Ian J IJ Soranzo Nicole N Koenig Wolfgang W Hayward Caroline C
Circulation 20110418 17
<h4>Background</h4>Fibrin fragment D-dimer, one of several peptides produced when crosslinked fibrin is degraded by plasmin, is the most widely used clinical marker of activated blood coagulation. To identity genetic loci influencing D-dimer levels, we performed the first large-scale, genome-wide association search.<h4>Methods and results</h4>A genome-wide investigation of the genomic correlates of plasma D-dimer levels was conducted among 21 052 European-ancestry adults. Plasma levels of D-dime ...[more]